Clinical Trial Update: Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema [NA]

View source ↗

Summary

Clinical trial update comparing bevacizumab versus aflibercept for diabetic macular edema is currently enrolling by invitation at CMH Multan Institute of Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• EYLEA (Aflibercept)

Snippet

Sponsor: CMH Multan Institute of Medical Sciences | Conditions: Diabetic Macular Edema (DME) | NA | Status: ENROLLING_BY_INVITATION